HIV 1 News and Research

RSS

New Rush clinic brings trained clinicians to care for patients with pulmonary hypertension

Cardiologists and pulmonologists at Rush University Medical Center have teamed up to provide a new and better approach to treating patients with pulmonary hypertension, a disease affecting the heart and lungs. The new Rush Pulmonary Hypertension Clinic brings together a multidisciplinary team of clinicians with specialized training to care for patients with this very complex disease.

16 Feb 2011

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Viral Genetics, Inc. announced today that lead researcher Dr. M. Karen Newell Rogers and Advisor Mr. Richard Gerstner will receive the Lauren F. Brooks Hope Award, presented by Time for Lyme, Inc.

16 Feb 2011

AHF condemns budget move by House Republicans for global AIDS programs

AIDS Healthcare Foundation, which provides AIDS medical care and services to more than 152,000 individuals in 26 countries worldwide, today strongly condemned a move by House Republicans, who on Friday proposed slashing President Obama's 2011 funding for global AIDS programs by $813 million.

16 Feb 2011

Girls Decide: Putting girls' sexual and reproductive health at the heart of development

There is a growing global consensus that girls are central to global development. Yet issues relating to girls’ sexuality and their sexual and reproductive rights continue to be largely neglected. Girls Decide, a new initiative from the International Planned Parenthood Federation (IPPF), highlights the importance of girls’ and young women’s sexual and reproductive lives for both individual and global development, and aims to ensure governments around the world to adopt policies that work for girls.

15 Feb 2011

ITM research provides deep insight into interactions between HIV virus and human cells

Over the years, the AIDS virus has increasingly adapted itself to humans. This is shown by the research of Youssef Gali at the Institute of Tropical Medicine.

15 Feb 2011

EMBL scientists reveal new insights into bacterial enzymes that causes tuberculosis

In a paper published today in PNAS, scientists from the European Molecular Biology Laboratory in Hamburg, Germany, reveal new insights into the workings of enzymes from a group of bacteria including Mycobacterium tuberculosis, the bacterium that causes tuberculosis.

15 Feb 2011

February is again peak time for influenza across the nation

If you thought the regular seasonal flu has been late making its annual appearance, you might be surprised to learn that based on recent history, it's right on time.

15 Feb 2011

TFAH applauds overall increase in disease prevention funding, expresses concern over CDC cuts

The Trust for America's Health (TFAH) applauds the President's budget for an overall increase in disease prevention funding, reflecting the new funds provided by the Prevention Fund from the Affordable Care Act (ACA), but expresses extreme concerns over the cuts to funding for core programs at the U.S. Centers for Disease Control and Prevention (CDC) and for emergency preparedness.

15 Feb 2011

Viewpoints: Expediting SCOTUS health law review; birth control funding; budget cutting and the stock market

Virginia Attorney General Ken Cuccinelli II has asked the U.S. Supreme Court to take the extraordinary step of leapfrogging past federal appeals courts to decide the constitutionality of the new health-care law.

15 Feb 2011

NIH awards renewal grant to BMC's CARE unit to expand education of physicians-in-training

The Clinical Addiction Research and Education Unit in the Section of General Internal Medicine at BMC was recently awarded a $1,886,087 renewal grant from the National Institutes of Health to expand its education of physicians-in-training to become sophisticated implementers of substance use screening, assessment and treatment research.

14 Feb 2011

FHC supports San Francisco's female condom campaign

The Female Health Company is supporting the launch of San Francisco's social marketing campaign to raise awareness and use of the FC2 Female Condom® among people living at risk of HIV infection. The FC2 Female Condom remains the only FDA-approved method of female-initiated HIV prevention available.

14 Feb 2011

Chimerix announces completion of $45 million Series F financing

Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F financing. New Leaf Venture Partners led the round, with participation by new investors Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.

14 Feb 2011

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).

14 Feb 2011

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Napo Pharmaceuticals, Inc. is pleased to announce the positive results of a successfully completed Phase 2 study of crofelemer for the treatment of hospitalized adult patients with mild to moderate acute watery diarrhea conducted by its partner Glenmark Pharmaceuticals Ltd..

14 Feb 2011

Janssen, Medivir collaborate to discover and develop drugs against dengue virus

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, announces today that it has signed a collaboration agreement with Janssen Pharmaceutica N.V. for the discovery and development of drugs for the prophylaxis and treatment of dengue virus infection.

14 Feb 2011

HIV infection in mothers reduces disease resistance in babies: Study

New research suggests that babies whose mothers have HIV, but are not HIV-infected themselves, are born with lower levels of specific proteins in their blood called antibodies, which fight infection, compared with babies not exposed to HIV.

13 Feb 2011

HIV trials and tribulations

A report published online February 8 in PLoS Medicine shows that mass behaviour changes could be credited with helping to remarkably reduce the number of people infected with HIV in Zimbabwe in recent years. These changes include declines in extramarital, commercial, and casual sexual relations, as well as a decline in multiple partners. These have been triggered by increased awareness of AIDS deaths and fear of infection and to some extent by the country’s economic deterioration.

13 Feb 2011

53 share a needle & HIV risk due to a clinic blunder

Over 50 patients at a private radiology clinic were given blood tests using a needle device meant for single-patient use. Authorities have launched an investigation into the matter. These patients are all at risk of hepatitis B, hepatitis C and HIV infection. These cancer patients will need testing for the viruses, and again in three months. They had visited the hospital for a positron emission tomography (PET) scan for cancer detection.

13 Feb 2011

Protective immunity against HIV can be achieved without presence of virus neutralizing antibodies in the blood

New research shows that protective immunity against HIV can be achieved without the presence of virus neutralizing antibodies in the blood. The study, published by Cell Press in the February issue of the journal Immunity, demonstrates that a vaccine which stimulates production of specific anti-HIV antibodies in the vaginal tissue was sufficient to protect monkeys from exposure to live virus.

11 Feb 2011

RF-induced heat therapy could help treat common parasitic skin infection

Scientists are hoping that heat therapy could eventually replace a complex drug regimen as the first-line treatment of a parasitic skin infection common in tropical and subtropical regions of the world.

11 Feb 2011

HIV 1 News and Research

New Rush clinic brings trained clinicians to care for patients with pulmonary hypertension

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

AHF condemns budget move by House Republicans for global AIDS programs

Girls Decide: Putting girls' sexual and reproductive health at the heart of development

ITM research provides deep insight into interactions between HIV virus and human cells

EMBL scientists reveal new insights into bacterial enzymes that causes tuberculosis

February is again peak time for influenza across the nation

TFAH applauds overall increase in disease prevention funding, expresses concern over CDC cuts

Viewpoints: Expediting SCOTUS health law review; birth control funding; budget cutting and the stock market

NIH awards renewal grant to BMC's CARE unit to expand education of physicians-in-training

FHC supports San Francisco's female condom campaign

Chimerix announces completion of $45 million Series F financing

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Janssen, Medivir collaborate to discover and develop drugs against dengue virus

HIV infection in mothers reduces disease resistance in babies: Study

HIV trials and tribulations

53 share a needle & HIV risk due to a clinic blunder

Protective immunity against HIV can be achieved without presence of virus neutralizing antibodies in the blood

RF-induced heat therapy could help treat common parasitic skin infection

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News